Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.
Journal: Neurochemical research
Published: May 08, 2026
Quercetin and 6-Br-quercetin: antioxidant properties and off target screening results advance glycosylated 6BrQ as developmental candidates for Alzheimer's disease.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Altering PTPRD via genetics or pharmacology modulates 3xTg-AD mouse neurofibrillary pathology.
Journal: Frontiers in neuroscience
Published: February 03, 2026
Wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, suppresses methamphetamine-induced stereotypy and hyperlocomotion in mice.
Journal: Behavioural pharmacology
Published: November 20, 2025
Pentilludin reduces rat amphetamine and remifentail self-administration with good pharmacologic and toxicologic profiles.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Ifenprodil inhibits nicotine-induced addiction-like behaviors in mice.
Journal: Life sciences
Published: July 29, 2025
Polygenic Risk for Substance Use Disorders as Predictors of Substance Use Initiation Among African American Youth.
Journal: Journal of studies on alcohol and drugs
Published: June 27, 2025
Alzheimer's disease prevention by flavonols and their analogs.
Journal: The journal of prevention of Alzheimer's disease
Published: May 03, 2025
Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice.
Journal: Behavioural pharmacology
Published: April 04, 2025
Polygenic Risk for Substance Use Disorders as Predictors of Substance Use Initiation Among African American Youth.
Journal: Journal of studies on alcohol and drugs
Published: November 21, 2024
Protein phosphatase 2A inhibitors: a possible pharmacotherapy for benzodiazepine dependence.
Journal: The Journal of pharmacy and pharmacology
Published: July 24, 2024
Opioid receptor antagonists reduce motivated wheel-running behavior in mice.
Journal: Behavioural pharmacology
Published: March 07, 2024
Last Updated: 09/26/2026